# The Impact of Air Travel on Passenger Cognitive Functions

> **NCT04802785** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Dinara Zhumanbayeva** · enrollment: 50 (estimated)

## Conditions studied

- Air Travel

## Interventions

- **DRUG:** Citicoline
- **DRUG:** Cytochrome C6
- **DRUG:** Sodium Chloride Oral Product
- **DRUG:** Potassium Chloride Oral Product
- **DRUG:** Sodium Citrate Oral Product
- **DRUG:** Dextrose Oral Tablet, Chewable
- **DRUG:** Domperidone Oral Product
- **DRUG:** Simethicone
- **DRUG:** Acetylsalicylic acid
- **DRUG:** Magnesium hydroxide
- **DRUG:** Probiotic Formula
- **DRUG:** Melatonin 5 mg

## Key facts

- **NCT ID:** NCT04802785
- **Lead sponsor:** Dinara Zhumanbayeva
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06
- **Primary completion:** 2021-07
- **Final completion:** 2022-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04802785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04802785, "The Impact of Air Travel on Passenger Cognitive Functions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04802785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*